Primary lymph node sites in Hodgkin lymphoma and the risk of second primary cancers: a population-based study.

Autor: Ebied A; Egyptian National Blood Transfusion Services, Therapeutic Department, Cairo, Egypt.; Online Research Club, Nagasaki, Japan., Yousif M; Online Research Club, Nagasaki, Japan.; Faculty of Medicine, University of Khartoum, Khartoum, Sudan., Nam NH; Online Research Club, Nagasaki, Japan.; Department of General Surgery, University of Medicine & Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Elhamamsy AR; Online Research Club, Nagasaki, Japan.; Faculty of Pharmacy, Tanta University, Tanta, Egypt., Hassan OG; Online Research Club, Nagasaki, Japan.; Faculty of Medicine, South Valley University, Qena, Egypt., Mostafa EM; Online Research Club, Nagasaki, Japan.; Faculty of Medicine, Port Said University, Port Said, Egypt., Nguyen GJ; Online Research Club, Nagasaki, Japan.; American University of Antigua College of Medicine, Antigua, Antigua & Barbuda., Hirayama K; Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852 8523, Japan., Huy NT; Evidence Based Medicine Research Group, Ton Duc Thang University, Ho Chi Minh City 70000, Vietnam.; Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City 70000, Vietnam.
Jazyk: angličtina
Zdroj: Future oncology (London, England) [Future Oncol] 2020 Mar; Vol. 16 (9), pp. 451-467. Date of Electronic Publication: 2020 Feb 25.
DOI: 10.2217/fon-2019-0703
Abstrakt: Aim: Little is known about the association between specific primary lymph node (LN) sites and the risk of developing second primary cancers in Hodgkin lymphoma (HL) patients. Materials & methods: To fill this knowledge gap, we used the multiple primary standardized incidence ratio function of the SEER*stat program to explore such an association for multiple latency periods. Results: Several SPCs occurred at various time points following different primary LN presentations of HL. Conclusion: HL survivors may benefit from a tailored primary LN site-specific follow-up screening.
Databáze: MEDLINE
Externí odkaz: